Sergey Postovsky
Research Subjects
Research Interests
Sergey Postovsky has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anat Ilivitzki
Rambam Health Care Campus
1 shared publication - Boris Sokolovski
Department of Radiology Pediatric Radiology Unit, Ruth Rappaport Children's Hospital, Rambam Health Care Campus Haifa Israel
1 shared publication - Leonid Malkin
Department of Pathology Rambam Health Care Campus Haifa Israel
1 shared publication - Michal Scolnik
Department of Radiology, Resident, Rambam Health Care Campus, Haifa, Israel
1 shared publication - Myriam Weyl Ben‐Arush
Department of Pediatric Hematology and Oncology Ruth Rappaport Children's Hospital, Rambam Health Care Campus Haifa Israel
1 shared publication
Latest Publications
- 3 April 2021
- Published by Wiley in Diagnostic Cytopathology
- Vol. 49 (7) , 817-821
Ultrasound‐guided core biopsy with on‐site cytology‐immediate diagnosis in pediatric oncology
Background Accurate and swift tissue diagnosis is extremely important for the timely initiation of treatment in pediatric oncology. In our department, ultrasound‐guided core needle biopsy (US‐guided CNB) is used for tissue diagnosis. In 2016, we added on‐site cytology, allowing for an immediate primary diagnosis. We retrospectively reviewed our performance in terms of safety and accuracy for CNBs and on‐site cytology. Methods All pediatric biopsies performed in our hospital between February 2016 and December 2020, were included. Patient clinical, procedural and follow‐up data were collected. CNB pathology and cytology results were compared to the final pathologic diagnosis. Results We included 71 patients for which 72 biopsies with on‐site touch imprint (TI) cytology were performed; the average latency time to biopsy was 1 day. Altogether, we had 61 tumors, (58 malignant, 3 benign) and 11 other lesions. On‐site cytology diagnosed 58 malignant tumors, 3 benign tumors and 11 non‐tumor tissues. The cytologist correctly differentiated tumor from inflammation in all cases, and diagnosed the precise tumor type in 57 cases, with an accuracy of 94% for final diagnosis. We had no complications related to the procedure or sedation. Conclusion US‐guided CNB with on‐site TI cytology for suspected malignancy in the pediatric population is highly available, safe, and accurate, with real‐time diagnosis in most cases. This accelerated diagnostic route has a huge impact on patient care.
- 3 April 2021
- Published by Wiley in Diagnostic Cytopathology
- Vol. 49 (7) , 817-821
Ultrasound‐guided core biopsy with on‐site cytology‐immediate diagnosis in pediatric oncology
Background Accurate and swift tissue diagnosis is extremely important for the timely initiation of treatment in pediatric oncology. In our department, ultrasound‐guided core needle biopsy (US‐guided CNB) is used for tissue diagnosis. In 2016, we added on‐site cytology, allowing for an immediate primary diagnosis. We retrospectively reviewed our performance in terms of safety and accuracy for CNBs and on‐site cytology. Methods All pediatric biopsies performed in our hospital between February 2016 and December 2020, were included. Patient clinical, procedural and follow‐up data were collected. CNB pathology and cytology results were compared to the final pathologic diagnosis. Results We included 71 patients for which 72 biopsies with on‐site touch imprint (TI) cytology were performed; the average latency time to biopsy was 1 day. Altogether, we had 61 tumors, (58 malignant, 3 benign) and 11 other lesions. On‐site cytology diagnosed 58 malignant tumors, 3 benign tumors and 11 non‐tumor tissues. The cytologist correctly differentiated tumor from inflammation in all cases, and diagnosed the precise tumor type in 57 cases, with an accuracy of 94% for final diagnosis. We had no complications related to the procedure or sedation. Conclusion US‐guided CNB with on‐site TI cytology for suspected malignancy in the pediatric population is highly available, safe, and accurate, with real‐time diagnosis in most cases. This accelerated diagnostic route has a huge impact on patient care.